SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1727MNTA ‘ReadMeFirst’ updated: <i>Updates since 3/2/08 version: new Lovenox DewDiligence_on_SI-4/30/2008
1726This is from Bear Stearns this afternoon. Momenta's CEO Craig Wheeler justrkrw-4/30/2008
1725Today’s MNTA webcast at Morgan Stanley conference is a must-listen for anyone wiDewDiligence_on_SI-4/30/2008
1724<i>I don't understand the ANDA process at all well, so my six-month reDewDiligence_on_SI-4/30/2008
1723<i>resubmission in early 2009?</i> Taking their PR at face value, tBiomaven-4/30/2008
1722So, would you expect resubmission in early 2009?idos-4/30/2008
1721<i>The good news—no clinical trials—was largely expected. The bad news—repBiomaven-4/30/2008
1720Probably no way to find out. Unless someone asks on their respective quarterly crkrw-4/30/2008
1719Copaxone logs record, <i>blowout</i> sales in 1Q08: siliconinvestorDewDiligence_on_SI-4/30/2008
1718<u>Annualized</u> 1Q08 Lovenox sales by region (as reported by SNY):DewDiligence_on_SI-4/30/2008
1717It seems to me that one of the interesting questions remaining open is whether FIRWIN JAMES FRANKEL-4/29/2008
1716Thanks. A friend had one and it and an MRI missed a cancer originating in his ofreelyhovering-4/29/2008
1715I think the submission will probably be closer to the end of 3Q08 (September) thDewDiligence_on_SI-4/29/2008
1714Doesn't 3Q08 start in 2 months in the US? :^)Ian@SI-4/29/2008
1713There's also the new info being asked for. Hopefully its supportive of approrkrw-4/29/2008
1712The good news—no clinical trials—was largely expected. The bad news—reply to FDADewDiligence_on_SI-4/29/2008
1711Momenta Pharmaceuticals Receives Regulatory Guidance On M-Enoxaparin ANDA Tuesdamopgcw-4/29/2008
1710<i>Where does mnta/sandoz source their product?</i> I don't thiBiomaven-4/29/2008
1709My apologies I must have misreadosofun-4/29/2008
1708I just read over the 8K you must be referring to and don't see where it indirkrw-4/29/2008
1707Ganish Venkatarman has left MNTA, anybody care to speculate why?osofun-4/29/2008
1706Where does mnta/sandoz source their product? I've heard Amphastar producesrkrw-4/29/2008
1705Momenta Pharmaceuticals upgraded to "market outperform" 4:30a.m. - RodLJM-4/29/2008
1704The scan mentioned in the article seems to be intended for use in optimally placBiomaven-4/28/2008
1703nytimes.com How is this heart scan different from other scans already used? Guefreelyhovering-4/28/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News